PRA Health Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PRA Health Sciences generated cash of $427,178,000, which is more than the previous year. Cash used in financing activities reached the amount of $77,429,000 last year. Net change in cash is therefore $270,033,000.
Cash Flow
| 2012 | 99.25M | -18.05M | -42.15M |
|---|---|---|---|
| 2013 | 25.26M | -1.07B | 1.07B |
| 2014 | 22.74M | -12.25M | 8.29M |
| 2015 | 153.67M | -71.68M | -42.44M |
| 2016 | 160.04M | -34.61M | -101.59M |
| 2017 | 220.40M | -687.42M | 507.00M |
| 2018 | 329.79M | -55.47M | -319.51M |
| 2019 | 253.56M | -73.18M | -90.70M |
| 2020 | 427.17M | -233.9M | 77.42M |
PRAH Cash Flow Statement (2012 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 236.27M | 144.70M | 192.89M | 149.33M | 126.12M | 85.19M | 72.15M | 109.21M | 69.38M |
Operating activities | |||||||||
Net income | 197.04M | 243.02M | 153.90M | 86.92M | 68.17M | 81.76M | -35.74M | 0 | -2.70M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 131.63M | 114.89M | 112.24M | 78.22M | 69.50M | 77.95M | 96.56M | 50.47M | 30.68M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.74M | 11.61M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.74M | 11.61M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -172.22M | -89.30M | -17.01M | -136.33M | -31.31M | -83.21M | -32.78M | 20.37M | 17.64M |
Inventories | 13.7M | 52.16M | 117.04M | 168.54M | -63.22M | -1.43M | -28.44M | 24.61M | 0 |
Accounts payable | 11.08M | 21.58M | 31.57M | 35.79M | -1.47M | 36.13M | 19.72M | 24.06M | 4.98M |
Cash generated by operating activities | 427.17M | 253.56M | 329.79M | 220.40M | 160.04M | 153.67M | 22.74M | 25.26M | 99.25M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -66.80M | -74.29M | -55.88M | -61.31M | -33.14M | -32.81M | -27.32M | -19.71M | -18.06M |
Acquisitions Net | -159M | 0 | 0 | -558M | -4M | -2M | 0 | 0 | 0 |
Cash generated by investing activities | -233.9M | -73.18M | -55.47M | -687.42M | -34.61M | -71.68M | -12.25M | -1.07B | -18.05M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 333.95M | 470.4M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -131.62M | -101.60M |
Repurchases of common stock | 0 | -300M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -122.5M | 0 | -315.89M | 0 | -950.38M | 0 | -423.77M | -619.55M | -224.04M |
Cash used in financing activities | 77.42M | -90.70M | -319.51M | 507.00M | -101.59M | -42.44M | 8.29M | 1.07B | -42.15M |
Net Change In Cash | 270.03M | 91.56M | -48.18M | 43.55M | 23.21M | 35.87M | 13.03M | -37.05M | 39.83M |
Cash at end of period | 506.30M | 236.27M | 144.70M | 192.89M | 149.33M | 121.06M | 85.19M | 72.15M | 109.21M |
| Data source | Data source | Data source | Data source | Data source | Data source |